Category : Healthcare and Pharmaceuticals | Published at : August-2022 | Delivery Format : PDF | Status: Published | Pages : 250
The Global Clinical Decision Support System Market Size is valued at USD 1,368 million in 2021 and is estimated to achieve a market size of USD 3,139 million by 2030; growing at a CAGR of 9.8%.
-Market,-2018-2030.png "Clinical Decision Support System Market Size 2022 - 2030")
Clinical decision support system (CDSS) is a health information system designed to patients, staff, clinicians, and other healthcare professionals with the patient specific information and intelligently filters or presents the information at appropriate times to improve health care process. This technology encompasses a variety of tools improve decision making in clinical workflow. CDSS solutions include computerized reminders and alerts, clinical guidelines, condition specific order sets, patient information records and summaries, diagnostic support, documentation template, and other relevant reference information. Other important benefits offered by CDSS include increased quality of health care and improved health outcomes, elimination in errors, cost benefit and improved efficiency, and patient and provider satisfaction.
Global Clinical Decision Support System (CDSS) Market DRO’s:
Market Drivers:
- Increasing adoption of EHRs
- Increase in demand for quality care and technical solutions
- Growing incidence of medication errors
- Rising importance and usage of big data and mHealth tools
Market Restraints:
- Data security concerns related to cloud-based CDSS
- Inadequate interoperability
Market Opportunities:
- The growth potential of emerging markets
- Government initiatives for better healthcare in developing countries
Clinical Decision Support System Market Report Coverage
| Market | Clinical Decision Support System Market |
| Clinical Decision Support System Market Size 2021 | USD 1,368 Million |
| Clinical Decision Support System Market Forecast 2030 | USD 3,139 Million |
| Clinical Decision Support System Market CAGR | 9.8% During 2022 - 2030 |
| Analysis Period | 2018 - 2030 |
| Base Year | 2021 |
| Forecast Data | 2022 - 2030 |
| Segments Covered | By Solutions, By Application, By Model, By Mode of Delivery, By Component, By Healthcare Entity Capacity, And By Region |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled | Cerner Corporation, Epic Systems Corporation, Allscripts Healthcare Solutions Inc., IBM Corporation, Relx Group Plc, Mckesson Corporation, General Electric Company, Siemens AG, Meditech, and Zynx Health Incorporated. |
| Report Coverage |
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
Clinical Decision Support System Market Dynamics
The global clinical decision support systems market is growing at a significant rate owing to the growing need of advanced healthcare information systems and increasing investments by health information technology (HIT) players. In addition, growing need for remote patient monitoring services and increasing support from government organizations is also driving the growth of global CDSS market. However, privacy and security concerns, high capital expenditure and maintenance requirement, and inadequate healthcare infrastructure in developing economies are inhibiting the growth of the global CDSS market. The increasing popularity of CDSS in healthcare facilities is the key trend observed in the global CDSS market.
CDSS and their software are gaining popularity in healthcare facilities, due to innovative and advanced applications such as, double-checking medication administration properties, drug reminders, and drug allergy alerts. These innovative and advanced applications of CDSS reduce chances of adverse drug events, and medication errors. Moreover, they improve healthcare quality, and reduce healthcare cost. In home healthcare settings, the CDSS integrated with medication management system plays a pivotal role in medication delivery and dosage calculations. Most patients cannot remember their entire medication regimen and forget to take their medication. In such conditions, CDSS integrated smartphone-based self-management systems with real-time medication monitoring technology reminds patients to take medication on time and prevent medication errors. Thus, these innovative applications of integrated CDSS attract end users to adopt the technology.
Clinical Decision Support System Market Segmentation
The market can be bifurcated on the basis of solutions, application, model, mode of delivery, component, healthcare entity capacity, and region.
Clinical Decision Support System Market by Solutions
- Integrated CDSS Solutions
- Standalone CDSS Solutions
Clinical Decision Support System Market by Application
- Drug Dosing Support
- Clinical Guidelines
- Clinical Reminders
- Drug-Drug Interactions
- Drug Allergy Alerts
- Others
Clinical Decision Support System Market by Model
- Knowledge-based CDSS Solutions
- Non-Knowledge-based CDSS Solutions
Clinical Decision Support System Market by Mode of Delivery
- On-Premises
- Web-Based
- Cloud-Based
Clinical Decision Support System Market by Component
- Software
- Hardware
- Services
Clinical Decision Support System Market by Healthcare Entity Capacity
- Less than 100 Beds
- 100–199 Beds
- 200–299 Beds
- 300–399 Beds
- 400–499 Beds
- More than 500 Beds
Clinical Decision Support System Market Regional Outlook
North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Increasing healthcare spending fuels the North America clinical decision support system market
North America was the largest market for CDSS in 2021 in terms of revenue generation, and accounted for more than 50% share. This region is expected to maintain its dominance throughout the forecast period majorly attributed by increased health spending on the region, improved healthcare infrastructure, rising prevalence of chronic illnesses and lifestyle associated diseases. For instance, according to American Diabetes Association (ADA), approximately 25.8 million people suffered from diabetes in 2010 and the number increased to 29.1 million in 2012. Further, rise in geriatric population in North America has positively impacted the growth of CDSS market.
Clinical Decision Support System Market Players
Among the player operating in the global CDSS market, some profiled in the report include Cerner Corporation, Epic Systems Corporation, Allscripts Healthcare Solutions Inc., IBM Corporation, Relx Group Plc, Mckesson Corporation, General Electric Company, Siemens AG, Meditech, and Zynx Health Incorporated among others. Partnership expansion, strategic relationships for technology sharing and development, and acquisitions are some major strategies followed by leading players in this market to sustain market competition.
Frequently Asked Questions
The global clinical decision support system market size in 2021 was accounted to be USD 1,368 Million.
The projected CAGR clinical decision support system market during the analysis period of 2022 to 2030 is 9.8%.
The prominent players of the global clinical decision support system market are Cerner Corporation, Epic Systems Corporation, Allscripts Healthcare Solutions Inc., IBM Corporation, Relx Group Plc, Mckesson Corporation, General Electric Company, Siemens AG, Meditech, and Zynx Health Incorporated.
North America held the dominating clinical decision support system during the analysis period of 2022 to 2030.
Asia-Pacific region exhibited fastest growing CAGR for clinical decision support system during the analysis period of 2022 to 2030.
Increasing adoption of EHRs, increase in demand for quality care and technical solutions, and growing Incidence of medication errors drives the growth of global clinical decision support system market.
Based on solutions, integrated CDSS solutions segment held the maximum share clinical decision support system market in 2021.
